Resisting recommended treatment for prostate cancer: a qualitative analysis of the lived experience of possible overdiagnosis.doi:10.1136/BMJOPEN-2018-026960Kirsten McCafferyBrooke NickelKristen PicklesRay MoynihanBarnett KramerAlexandra BarrattJolyn Hersch...
(IGF-1) receptor signaling in prostate cancer cells. Luteolin and apigenin have also been shown increase the anti-cancer effects of the chemotherapy drugTaxol(paclitaxel). Celery consumption has been found to be associated with lower risks of lung, ovarian, gastric and colorectal cancers in ...
Breast cancer-related effects of eating parsley A major Italian population study including 2,569 women with breast cancer found that the risk of breast cancer was reduced for increasing intake of flavones and flavonols found in parsley. Parsley is a source of the flavonesapigenin,luteolin, chrysoeri...
Palladium-103 (T1/2 = 16.991 d) decaying 100% by electron capture, accompanied by emission of Auger electrons and low energy X-rays, is extensively used in the treatment of prostate cancer and ocular melanoma. Applied mostly in brachytherapy form. Rhodium-102 (metastable and ground state)...
AstraZeneca and MSD’s Lynparza (olaparib) in combination with abiraterone and prednisone or prednisolone has been recommended for marketing authorisation in the European Union (EU) for the treatment of adult patients with metastatic castration-resistant prostate cancer (mCRPC) for wh...
Skill Checkup: A 56-Year-Old Man With Treated Nonobstructing Resectable Colon Cancer Has Metachronous Metastases 2001/viewarticle/1000364 New Guidance for the Treatment of Metastatic Breast Cancer b:recommendationscuratedHasData : falseEmail This Feedback Help us make reference on Medscape the ...
integrated health care delivery system of 500 patients who received curative treatment of breast, colorectal, endometrial, lung, or prostate cancer. Our measures were the indications for potential surveillance procedures as recommended by clinical practice guidelines or otherwise. Among 14,670 procedures ...
The proportions of patients who went through the CPP within the recommended time frames were highest among colon (84%) and breast (76%) cancer patients who underwent surgery and lung cancer patients who started systemic anticancer treatment (76%), and lowest for prostate cancer patients who ...
Last month, the KBCS released the 10th Korean Breast Cancer Treatment Recommendations, which includes the latest treatment guidelines for breast cancer, including adjuvant therapy after lumpectomy. In the revised recommendation, Lynparza has been updated to the Level of Evidence 1, Class of Recommenda...
“[Tivozanib’s] addition to the NCCN Guidelines provides further validation for its potential to serve as an important evidence-based, well-tolerated treatment option for patients with relapsed or refractory advanced RCC,” Michael Bailey, president and chief executive officer of AVEO, stated...